Oura has entered into a definitive agreement to acquire AI-powered primary care provider Counsel Health for $625 million in cash, subject to customary adjustments. Expected to close before the end of 2026, the transaction will integrate Oura’s continuous biometric monitoring capabilities with Counsel Health’s clinically supervised artificial intelligence and physician-led healthcare services.
The acquisition will enable Oura’s approximately six million members to access medical guidance, clinical assessments, prescriptions, and specialist referrals directly through the Oura App. Counsel Health’s AI platform will support initial medical inquiries and triage, with users able to escalate consultations to board-certified physicians within minutes.
Oura currently monitors more than 50 biometric markers, providing longitudinal physiological data that could inform clinical decision-making. Counsel Health, founded by Dr. Muthu Alagappan, operates an AI-supported clinical platform that combines medical literature, diagnostic guidelines, patient records, and physician oversight.
Its proprietary “Clinician Cockpit” consolidates medical histories and physiological trends, allowing clinicians to evaluate patient concerns alongside continuous biometric measurements. Internal evaluations indicate that more than 90% of members reported improved clinical experiences when biometric context was incorporated, with average satisfaction reaching 4.6 out of 5.
The acquisition follows substantial financial growth at Oura. For the fiscal quarter ending September 30, 2026, revenue increased 153% year-over-year to $533 million, alongside adjusted EBITDA of $87 million. Full-year fiscal revenue approached $1.75 billion.
The combined platform will initially focus on three clinical areas: preventive care, including early identification of physiological changes; acute care, encompassing medical triage, prescriptions, and diagnostic testing; and chronic and specialty care, covering cardiometabolic health, hormonal conditions, and aging.
The integration could also expand Oura’s presence among employers, insurers, and healthcare systems through Counsel Health’s existing institutional relationships.
“Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals,” said Tom Hale, Chief Executive Officer of Oura.
The transaction represents Oura’s planned expansion from consumer health monitoring into integrated clinical services, although implementation will require attention to patient privacy, clinical reliability, and AI oversight.
Click here for the original news story.
